Back
Protagonist Therapeutics Vs. Morphic Holding Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
33.37
Seasonality Move:
14.81%
Buy
57
MORF
Morphic Holding
Last Price:
26.42
Seasonality Move:
11.46%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $33.39. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Morphic Holding (MORF)
is a Buy
Is Morphic Holding a Buy, Sell or Hold?
- The current Morphic Holding [MORF] share price is $26.45. The Score for MORF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MORF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $33.39
The current trend is moderately bullish and PTGX is experiencing slight selling pressure.
MORF Stock Price Chart
What is Morphic Holding's stock price today?
-
The Morphic Holding share price today is $26.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MORF is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 60.08 | Buy |
| Chaikin Money Flow: | -119501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.07 - 33.45) | Buy |
| Bollinger Bands (100): | (26 - 31.02) | Buy |
MORF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 38.58 | Sell |
| Chaikin Money Flow: | -130278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.26 - 31.22) | Sell |
| Bollinger Bands (100): | (28.59 - 35.83) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.96 | Sell |
| 20-day SMA: | 31.55 | Buy |
| 50-day SMA: | 28.85 | Buy |
| 200-day SMA: | 23.59 | Buy |
| 8-day EMA: | 33.27 | Buy |
| 20-day EMA: | 31.77 | Buy |
| 50-day EMA: | 29.87 | Buy |
| 200-day EMA: | 25.42 | Buy |
MORF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.37 | Sell |
| 20-day SMA: | 29.75 | Sell |
| 50-day SMA: | 29.32 | Sell |
| 200-day SMA: | 30.74 | Sell |
| 8-day EMA: | 28.64 | Sell |
| 20-day EMA: | 29.41 | Sell |
| 50-day EMA: | 30.02 | Sell |
| 200-day EMA: | 32.84 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Morphic Holding Earnings Growth & MORF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.30 per share.
Protagonist Therapeutics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Morphic Holding Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||